FDA Approves Herceptin Biosimilar

Options
Moderators
Moderators Member Posts: 25,912

FDA Approves Herceptin Biosimilar
December 1, 2017

The FDA has approved Ogivri, a biosimilar to Herceptin, to treat HER2-positive breast cancer. Read more...

Categories